Who owns Context Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CNTX from SEC Form 13F filings across 87 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 87 institutions disclosed 58.7M shares of Context Therapeutics Inc. worth $17.6M — about 61.6% of shares outstanding; the largest disclosed holder is Nextech Invest Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
87
13F holders
$17.6M
value, 2026 filers
61.6%
of shares outstanding (58.7M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CNTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Nextech Invest Ltd. | 7.4M | $2.2M | 0.1% | 7.8% | 0.0% |
| 2 | Deep Track Capital, LP | 7.4M | $2.2M | 0.0% | 7.8% | 0.0% |
| 3 | Soleus Capital Management, L.P. | 7.1M | $2.1M | 0.1% | 7.4% | 0.0% |
| 4 | BlackRock, Inc. | 6.1M | $1.8M | 0.0% | 6.4% | -0.5% |
| 5 | Avidity Partners Management LP | 4.1M | $1.2M | 0.2% | 4.3% | -18.8% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | $1.0M | 0.0% | 3.6% | 0.0% |
| 7 | AQR CAPITAL MANAGEMENT LLCNEW | 2.9M | $880,553 | 0.0% | 3.1% | new |
| 8 | TCG Crossover Management, LLC | 2.7M | $805,882 | 0.0% | 2.8% | 0.0% |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 2.0M | $597,000 | 0.0% | 2.1% | +96.9% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $569,501 | 0.0% | 2% | +3.6% |
| 11 | STATE STREET CORP | 1.5M | $437,352 | 0.0% | 1.5% | +3.0% |
| 12 | Verdad Advisers, LP | 1.1M | $340,454 | 0.4% | 1.2% | +3243.2% |
| 13 | CITADEL ADVISORS LLC | 995,887 | $299,164 | 0.0% | 1% | +5644.0% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 967,475 | $290,629 | 0.0% | 1% | -7.1% |
| 15 | LUMINUS MANAGEMENT LLCNEW | 913,715 | $274,480 | 0.2% | 1% | new |
| 16 | ADAR1 Capital Management, LLC | 750,969 | $225,591 | 0.0% | 0.8% | 0.0% |
| 17 | Russell Investments Group, Ltd. | 671,074 | $201,589 | 0.0% | 0.7% | +8907.7% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 634,673 | $190,402 | 0.0% | 0.7% | -0.7% |
| 19 | NORTHERN TRUST CORP | 623,027 | $187,157 | 0.0% | 0.7% | +1.2% |
| 20 | UBS Group AG | 524,545 | $157,364 | 0.0% | 0.6% | +1761.2% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 428,125 | $128,438 | 0.0% | 0.4% | -1.3% |
| 22 | GOLDMAN SACHS GROUP INC | 416,207 | $125,029 | 0.0% | 0.4% | +3259.5% |
| 23 | Squarepoint Ops LLC | 298,482 | $89,664 | 0.0% | 0.3% | +466.3% |
| 24 | BARCLAYS PLC | 297,854 | $89,475 | 0.0% | 0.3% | +982.9% |
| 25 | CANTOR FITZGERALD, L. P.NEW | 260,000 | $78,104 | 0.0% | 0.3% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.